Arthroplasty today · 2026
Parkinson's Disease Patients Face Higher 90-Day Readmission, Reoperation, and Infection Risk Following Total Knee Arthroplasty.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Maman David, Steinfeld Yaniv, Berkovich Yaron
Аннотация
BACKGROUND: Parkinson's disease (PD) is an increasingly common comorbidity in patients undergoing total knee arthroplasty (TKA), yet its impact on readmissions remains poorly defined.
METHODS: Using the Nationwide Readmissions Database 2020-2022, we identified elective, primary TKA cases. Patients with oncologic diagnoses, COVID-19-related admissions, acute fractures, and contralateral knee arthroplasty were excluded. Only the first readmission within 90 days was analyzed. Propensity score matching (1:1) was performed for demographics, comorbidities, hospital factors, and primary payer. The primary outcome was 90-day readmission. Secondary outcomes included infection-related readmissions, surgical procedures during readmission, readmission length of stay, readmission costs, and in-hospital mortality.
RESULTS: After matching, 7286 patients were included (3675 PD vs 3611 non-PD). PD patients had a significantly higher 90-day readmission rate (13.0% vs 7.3%; P < .01). Infection-related readmissions (4.1% vs 2.2%; P < .01) and surgical procedures during readmission (7.5% vs 4.1%; P < .01) were more frequent in PD patients. Readmission length of stay was longer (5.9 vs 4.1 days; P < .01), and readmission costs were higher ($63,023 vs $48,855; P < .01). In-hospital mortality during readmission was also higher in PD patients (0.3% vs 0.1%; P < .01).
CONCLUSIONS: PD is associated with a significantly higher risk of 90-day readmission following TKA, with readmissions frequently involving infection-related complications and surgical intervention. These findings highlight the importance of tailored perioperative care and enhanced postdischarge monitoring in this vulnerable population.
LEVELS OF EVIDENCE: Level III.
METHODS: Using the Nationwide Readmissions Database 2020-2022, we identified elective, primary TKA cases. Patients with oncologic diagnoses, COVID-19-related admissions, acute fractures, and contralateral knee arthroplasty were excluded. Only the first readmission within 90 days was analyzed. Propensity score matching (1:1) was performed for demographics, comorbidities, hospital factors, and primary payer. The primary outcome was 90-day readmission. Secondary outcomes included infection-related readmissions, surgical procedures during readmission, readmission length of stay, readmission costs, and in-hospital mortality.
RESULTS: After matching, 7286 patients were included (3675 PD vs 3611 non-PD). PD patients had a significantly higher 90-day readmission rate (13.0% vs 7.3%; P < .01). Infection-related readmissions (4.1% vs 2.2%; P < .01) and surgical procedures during readmission (7.5% vs 4.1%; P < .01) were more frequent in PD patients. Readmission length of stay was longer (5.9 vs 4.1 days; P < .01), and readmission costs were higher ($63,023 vs $48,855; P < .01). In-hospital mortality during readmission was also higher in PD patients (0.3% vs 0.1%; P < .01).
CONCLUSIONS: PD is associated with a significantly higher risk of 90-day readmission following TKA, with readmissions frequently involving infection-related complications and surgical intervention. These findings highlight the importance of tailored perioperative care and enhanced postdischarge monitoring in this vulnerable population.
LEVELS OF EVIDENCE: Level III.